Skip to main content
Erschienen in: Osteoporosis International 3/2020

14.12.2019 | Original Article

Diabetes and fractures: new evidence of atypical femoral fractures?

verfasst von: N.H. Rasmussen, J. Dal, F. de Vries, J.P. van den Bergh, M.H. Jensen, P. Vestergaard

Erschienen in: Osteoporosis International | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Summary

Patients with diabetes have an increased risk of fractures. In this study, subtrochanteric and femoral shaft fractures were increased in patients with type 1 diabetes compared with the general population. In the light of this, more evidence points towards an association between diabetes and atypical femoral fractures.

Introduction

Patients with diabetes have an increased risk of femoral fractures, but little is known about the risk of atypical femoral fractures (AFFs). The aim of this study was to identify the risk of subtrochanteric and femoral shaft (ST/FS) fractures and estimate the risk of AFFs in patients with type 1 (T1D) and type 2 diabetes (T2D).

Methods

From the nationwide Danish National Patient Register, we identified patients with T1D (n = 19,896), T2D (n = 312,188), and sex- and aged-matched controls without diabetes (n = 996,252) from the general population and all ST/FS fractures (n = 7509). Data were analyzed using a Cox proportional-hazards model and the incidence rate and rate ratio of ST/FS fractures were estimated.

Results

The incidence rate of ST/FS fractures in T1D was 52.14 events per 100,000 person years and 73.21 per 100,000 person years in T2D. T1D was associated with an increased risk of ST/FS (HR 2.07 (95% CI 1.68–2.56)), whereas T2D was not (HR 0.99 (95% CI 0.94–1.10)). Previous ST/FS fractures were associated with an increased risk of subsequent ST/FS fractures (HR 6.95 (95% CI 6.00–8.05)) and the use of bisphosphonates with an increased risk of ST/FS fractures (HR 1.72 (95% CI 1.54–1.91)).

Conclusion

Patients with T1D have a higher risk of ST/FS fractures compared with sex- and age-matched controls. Since a proportion of ST/FS fractures are classified as AFFs, this could point towards the fact that AFFs also are increased in patients with T1D, but not T2D.
Literatur
1.
Zurück zum Zitat Adler RA (2016) Bisphosphonates and atypical femoral fractures. Curr Opin Endocrinol Diabetes Obes 23:430–434CrossRef Adler RA (2016) Bisphosphonates and atypical femoral fractures. Curr Opin Endocrinol Diabetes Obes 23:430–434CrossRef
2.
Zurück zum Zitat Adler RA (2018) Management of endocrine disease: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy. Eur J Endocrinol 178:R81–R87CrossRef Adler RA (2018) Management of endocrine disease: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy. Eur J Endocrinol 178:R81–R87CrossRef
3.
Zurück zum Zitat Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263–268PubMed Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263–268PubMed
4.
Zurück zum Zitat Armamento-Villareal R, Napoli N, Panwar V, Novack D (2006) Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis. N Engl J Med 355:2048–2050CrossRef Armamento-Villareal R, Napoli N, Panwar V, Novack D (2006) Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis. N Engl J Med 355:2048–2050CrossRef
5.
Zurück zum Zitat Aspenberg P (2014) Denosumab and atypical femoral fractures. Acta Orthop 85:1–1CrossRef Aspenberg P (2014) Denosumab and atypical femoral fractures. Acta Orthop 85:1–1CrossRef
6.
Zurück zum Zitat Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC, Fracture Intervention Trial Steering Committee, HORIZON Pivotal Fracture Trial Steering Committee (2010) Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med 362:1761–1771CrossRef Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC, Fracture Intervention Trial Steering Committee, HORIZON Pivotal Fracture Trial Steering Committee (2010) Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med 362:1761–1771CrossRef
7.
Zurück zum Zitat Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. J Am Med Assoc 297:387–394CrossRef Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. J Am Med Assoc 297:387–394CrossRef
8.
Zurück zum Zitat Ensrud KE (2013) Epidemiology of fracture risk with advancing age. Journals Gerontol Ser A Biol Sci Med Sci 68:1236–1242CrossRef Ensrud KE (2013) Epidemiology of fracture risk with advancing age. Journals Gerontol Ser A Biol Sci Med Sci 68:1236–1242CrossRef
9.
Zurück zum Zitat Farlay D, Armas LA, Gineyts E, Akhter MP, Recker RR, Boivin G (2016) Nonenzymatic glycation and degree of mineralization are higher in bone from fractured patients with type 1 diabetes mellitus. J Bone Miner Res 31:190–195CrossRef Farlay D, Armas LA, Gineyts E, Akhter MP, Recker RR, Boivin G (2016) Nonenzymatic glycation and degree of mineralization are higher in bone from fractured patients with type 1 diabetes mellitus. J Bone Miner Res 31:190–195CrossRef
10.
Zurück zum Zitat Feldstein AC, Black D, Perrin N et al (2012) Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res 27:977–986CrossRef Feldstein AC, Black D, Perrin N et al (2012) Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res 27:977–986CrossRef
11.
Zurück zum Zitat Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287:2398–2399CrossRef Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287:2398–2399CrossRef
12.
Zurück zum Zitat Giusti A, Hamdy NAT, Dekkers OM, Ramautar SR, Dijkstra S, Papapoulos SE (2011) Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone 48:966–971CrossRef Giusti A, Hamdy NAT, Dekkers OM, Ramautar SR, Dijkstra S, Papapoulos SE (2011) Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone 48:966–971CrossRef
13.
Zurück zum Zitat Hopkins RB, Pullenayegum E, Goeree R, Adachi JD, Papaioannou A, Leslie WD, Tarride JE, Thabane L (2012) Estimation of the lifetime risk of hip fracture for women and men in Canada. Osteoporos Int 23:921–927CrossRef Hopkins RB, Pullenayegum E, Goeree R, Adachi JD, Papaioannou A, Leslie WD, Tarride JE, Thabane L (2012) Estimation of the lifetime risk of hip fracture for women and men in Canada. Osteoporos Int 23:921–927CrossRef
14.
Zurück zum Zitat Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL (2017) Mechanisms in endocrinology: Diabetes mellitus, a state of low bone turnover – a systematic review and meta-analysis. Eur J Endocrinol 176:R137–R157CrossRef Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL (2017) Mechanisms in endocrinology: Diabetes mellitus, a state of low bone turnover – a systematic review and meta-analysis. Eur J Endocrinol 176:R137–R157CrossRef
15.
Zurück zum Zitat Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505CrossRef Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505CrossRef
16.
Zurück zum Zitat Johansson H, Kanis JA, Odén A, McCloskey E, Chapurlat RD, Christiansen C, Cummings SR, Diez-Perez A, Eisman JA, Fujiwara S, Glüer CC, Goltzman D, Hans D, Khaw KT, Krieg MA, Kröger H, LaCroix A, Lau E, Leslie WD, Mellström D, Melton LJ 3rd, O'Neill TW, Pasco JA, Prior JC, Reid DM, Rivadeneira F, van Staa T, Yoshimura N, Zillikens MC (2014) A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 29:223–233 Johansson H, Kanis JA, Odén A, McCloskey E, Chapurlat RD, Christiansen C, Cummings SR, Diez-Perez A, Eisman JA, Fujiwara S, Glüer CC, Goltzman D, Hans D, Khaw KT, Krieg MA, Kröger H, LaCroix A, Lau E, Leslie WD, Mellström D, Melton LJ 3rd, O'Neill TW, Pasco JA, Prior JC, Reid DM, Rivadeneira F, van Staa T, Yoshimura N, Zillikens MC (2014) A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 29:223–233
17.
Zurück zum Zitat Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742CrossRef Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742CrossRef
18.
Zurück zum Zitat Khosla S, Bilezikian JP, Dempster DW, Lewiecki EM, Miller PD, Neer RM, Recker RR, Shane E, Shoback D, Potts JT (2012) Benefits and risks of bisphosphonate therapy for osteoporosis. J Clin Endocrinol Metab 97:2272–2282CrossRef Khosla S, Bilezikian JP, Dempster DW, Lewiecki EM, Miller PD, Neer RM, Recker RR, Shane E, Shoback D, Potts JT (2012) Benefits and risks of bisphosphonate therapy for osteoporosis. J Clin Endocrinol Metab 97:2272–2282CrossRef
19.
Zurück zum Zitat Khow KSF, Shibu P, Yu SCY, Chehade MJ, Visvanathan R (2017) Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: a systematic review. J Nutr Health Aging 21:83–91CrossRef Khow KSF, Shibu P, Yu SCY, Chehade MJ, Visvanathan R (2017) Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: a systematic review. J Nutr Health Aging 21:83–91CrossRef
20.
Zurück zum Zitat LeBlanc ES, Rosales AG, Black DM, Genant HK, Dell RM, Friess DM, Boardman DL, Bauer DC, de Papp A, Santora AC, Orwoll ES (2017) Evaluating atypical features of femur fractures: how change in radiological criteria influenced incidence and demography of atypical femur fractures in a community setting. J Bone Miner Res 32:2304–2314CrossRef LeBlanc ES, Rosales AG, Black DM, Genant HK, Dell RM, Friess DM, Boardman DL, Bauer DC, de Papp A, Santora AC, Orwoll ES (2017) Evaluating atypical features of femur fractures: how change in radiological criteria influenced incidence and demography of atypical femur fractures in a community setting. J Bone Miner Res 32:2304–2314CrossRef
22.
Zurück zum Zitat Leclerc J-T, Michou L, Vaillancourt F, Pelet S, Simonyan D, Belzile EL (2019) Prevalence and characteristics of atypical periprosthetic femoral fractures. J Bone Miner Res 34:83–92CrossRef Leclerc J-T, Michou L, Vaillancourt F, Pelet S, Simonyan D, Belzile EL (2019) Prevalence and characteristics of atypical periprosthetic femoral fractures. J Bone Miner Res 34:83–92CrossRef
23.
Zurück zum Zitat Lee K-J, Min B-W (2018) Surgical treatment of the atypical femoral fracture: overcoming femoral bowing. Hip pelvis 30:202–209CrossRef Lee K-J, Min B-W (2018) Surgical treatment of the atypical femoral fracture: overcoming femoral bowing. Hip pelvis 30:202–209CrossRef
24.
Zurück zum Zitat Lim S-J, Yeo I, Yoon P-W, Yoo JJ, Rhyu K-H, Han S-B, Lee W-S, Song J-H, Min B-W, Park Y-S (2018) Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study. Osteoporos Int 29:2427–2435CrossRef Lim S-J, Yeo I, Yoon P-W, Yoo JJ, Rhyu K-H, Han S-B, Lee W-S, Song J-H, Min B-W, Park Y-S (2018) Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study. Osteoporos Int 29:2427–2435CrossRef
25.
Zurück zum Zitat Lo JC, Huang SY, Lee GA, Khandewal S, Provus J, Ettinger B, Gonzalez JR, Hui RL, Grimsrud CD, Grimsrud CD (2012) Clinical correlates of atypical femoral fracture. Bone 51:181–184CrossRef Lo JC, Huang SY, Lee GA, Khandewal S, Provus J, Ettinger B, Gonzalez JR, Hui RL, Grimsrud CD, Grimsrud CD (2012) Clinical correlates of atypical femoral fracture. Bone 51:181–184CrossRef
26.
Zurück zum Zitat Lynge E, Sandegaard JL, Rebolj M (2011) The Danish National Patient Register. Scand J Public Health 39:30–33CrossRef Lynge E, Sandegaard JL, Rebolj M (2011) The Danish National Patient Register. Scand J Public Health 39:30–33CrossRef
27.
Zurück zum Zitat Medda S, Pilson H (2019) Subtrochanteric femur fractures. StatPearls Publishing Medda S, Pilson H (2019) Subtrochanteric femur fractures. StatPearls Publishing
28.
Zurück zum Zitat Meier RPH, Perneger TV, Stern R, Rizzoli R, Peter RE (2012) Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med 172:930–936PubMed Meier RPH, Perneger TV, Stern R, Rizzoli R, Peter RE (2012) Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med 172:930–936PubMed
29.
Zurück zum Zitat Napoli N, Schwartz AV, Palermo L, Jin JJ, Wustrack R, Cauley JA, Ensrud KE, Kelly M, Black DM (2013) Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures. J Clin Endocrinol Metab 98:659–667CrossRef Napoli N, Schwartz AV, Palermo L, Jin JJ, Wustrack R, Cauley JA, Ensrud KE, Kelly M, Black DM (2013) Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures. J Clin Endocrinol Metab 98:659–667CrossRef
30.
Zurück zum Zitat Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305:783CrossRef Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305:783CrossRef
33.
Zurück zum Zitat Samelson EJ, Demissie S, Cupples LA, Zhang X, Xu H, Liu CT, Boyd SK, McLean R, Broe KE, Kiel DP, Bouxsein ML (2018) Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT Study. J Bone Miner Res 33:54–62CrossRef Samelson EJ, Demissie S, Cupples LA, Zhang X, Xu H, Liu CT, Boyd SK, McLean R, Broe KE, Kiel DP, Bouxsein ML (2018) Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT Study. J Bone Miner Res 33:54–62CrossRef
34.
Zurück zum Zitat Sarodnik C, Bours SPG, Schaper NC et al (2018) Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Osteoporos Int 18:427–444 Sarodnik C, Bours SPG, Schaper NC et al (2018) Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Osteoporos Int 18:427–444
35.
Zurück zum Zitat Schilcher J, Michaëlsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 364:1728–1737CrossRef Schilcher J, Michaëlsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 364:1728–1737CrossRef
36.
Zurück zum Zitat Schilcher J, Koeppen V, Aspenberg P, Michaëlsson K (2015) Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop 86:100–107CrossRef Schilcher J, Koeppen V, Aspenberg P, Michaëlsson K (2015) Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop 86:100–107CrossRef
37.
Zurück zum Zitat Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449CrossRef Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449CrossRef
38.
Zurück zum Zitat Shah VN, Shah CS, Snell-Bergeon JK et al (2015) Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med 32:1134–1142CrossRef Shah VN, Shah CS, Snell-Bergeon JK et al (2015) Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med 32:1134–1142CrossRef
39.
Zurück zum Zitat Shanbhogue VV, Hansen S, Frost M, Jørgensen NR, Hermann AP, Henriksen JE, Brixen K (2015) Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with type 1 diabetes mellitus. J Bone Miner Res 30:2188–2199CrossRef Shanbhogue VV, Hansen S, Frost M, Jørgensen NR, Hermann AP, Henriksen JE, Brixen K (2015) Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with type 1 diabetes mellitus. J Bone Miner Res 30:2188–2199CrossRef
40.
Zurück zum Zitat Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen M, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1–23CrossRef Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen M, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1–23CrossRef
41.
Zurück zum Zitat Sing C-W, Woo Y-C, Lee ACH, Lam JKY, Chu JKP, Wong ICK, Cheung C-L (2017) Validity of major osteoporotic fracture diagnosis codes in the Clinical Data Analysis and Reporting System in Hong Kong. Pharmacoepidemiol Drug Saf 26:973–976CrossRef Sing C-W, Woo Y-C, Lee ACH, Lam JKY, Chu JKP, Wong ICK, Cheung C-L (2017) Validity of major osteoporotic fracture diagnosis codes in the Clinical Data Analysis and Reporting System in Hong Kong. Pharmacoepidemiol Drug Saf 26:973–976CrossRef
43.
Zurück zum Zitat Starup-Linde J, Hygum K, Langdahl BL (2018) Skeletal fragility in type 2 diabetes mellitus. Endocrinol Metab 33:339CrossRef Starup-Linde J, Hygum K, Langdahl BL (2018) Skeletal fragility in type 2 diabetes mellitus. Endocrinol Metab 33:339CrossRef
44.
Zurück zum Zitat Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int 18:427–444CrossRef Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int 18:427–444CrossRef
45.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L (2011) Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int 88:209–214CrossRef Vestergaard P, Rejnmark L, Mosekilde L (2011) Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int 88:209–214CrossRef
46.
Zurück zum Zitat Wallach Kildemoes H, Toft Sørensen H, Hallas J (2011) The Danish National Prescription Registry. Scand J Public Health 39:38–41CrossRef Wallach Kildemoes H, Toft Sørensen H, Hallas J (2011) The Danish National Prescription Registry. Scand J Public Health 39:38–41CrossRef
Metadaten
Titel
Diabetes and fractures: new evidence of atypical femoral fractures?
verfasst von
N.H. Rasmussen
J. Dal
F. de Vries
J.P. van den Bergh
M.H. Jensen
P. Vestergaard
Publikationsdatum
14.12.2019
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 3/2020
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-019-05224-y

Weitere Artikel der Ausgabe 3/2020

Osteoporosis International 3/2020 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.